No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
The aim of this study was to test the effects of the KIF6 Trp719Arg polymorphism (rs20455) on vascular risk and response to statin therapy in 18,348 participants from the Heart Protection Study.
Détails bibliographiques
| Auteurs principaux: |
Hopewell, J,
Parish, S,
Clarke, R,
Armitage, J,
Bowman, L,
Hager, J,
Lathrop, M,
Collins, R,
MRC/BHF Heart Protection Study Collaborative Group |
|---|
| Format: | Journal article
|
|---|
| Langue: | English |
|---|
| Publié: |
2011
|
|---|